A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients [clinicaltrials:NCT00001086]
A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients [clinicaltrials:NCT00001086]
Bio2RDF identifier
NCT00001086
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00001086
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
To compare the virologi ...... elow the limits of detection.
brief title [clinicaltrials_vocabulary:brief-title]
A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients
completion date [clinicaltrials_vocabulary:completion-date]
1999-09-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Therapeutically, there ...... y or all of the study drugs.]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-02T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Anti-HIV Agents
Drug Therapy, Combination
HIV Protease Inhibitors
RNA, Viral
Reverse Transcriptase Inhibitors
Viral Load
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-07-26T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00001086
official title [clinicaltrials_vocabulary:official-title]
A Randomized, Phase II, Placeb ...... A Rollover Study for ACTG 320
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2013-07-01T00:00:00Z
identifier
clinicaltrials:NCT00001086
title
A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients
@en
type
label
A Study of Abacavir Plus Indin ...... s [clinicaltrials:NCT00001086]
@en